July 2019 FDA Recall Nystatin And Triamcinolone Acetonide by Lupin Pharmaceuticals Inc.
D-1518-2019 - Failed Content Uniformity Specifications

This Class III drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on July 17, 2019 for the product Nystatin And Triamcinolone Acetonide. The FDA reported the reason for recall as failed content uniformity specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1518-2019

Reason for Recall
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.
Initiated
07-17-2019
Reported
07-31-2019
Quantity
33,939 tubes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Lupin Pharmaceuticals Inc.
Nationwide within the United States
Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01

Batch or Lot Expiration Information

Lot# : K800245, Exp. Dec 2019; K900036 Exp. Sep 20; K900153, Exp. 09/2020